Penumbra

Penumbra EBIT

The EBIT of Penumbra (PEN) as of Oct 29, 2026 is 189.25 M USD. In the previous year, EBIT was 86.22 M USD — a change of 119.49% (higher).

EBIT

189.25 MUSD

YoY

119.49%

Last updated:

In 2025, Penumbra's EBIT was 189.25 M USD, a 119.49% increase from the 86.22 M USD EBIT recorded in the previous year.

The Penumbra EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
6.08 M USD
Jan 1, 2023
73.55 M USD
Jan 1, 2024
86.22 M USD
Jan 1, 2025
189.25 M USD
Jan 1, 2026 (e)
243.10 M USD
Jan 1, 2027 (e)
313.84 M USD
Jan 1, 2028 (e)
365.38 M USD
Jan 1, 2029 (e)
398.39 M USD
The Penumbra EBIT history
YEAREBITYoY
est398.39 MUSD+9.03%
est365.38 MUSD+16.42%
est313.84 MUSD+29.10%
est243.10 MUSD+28.46%
189.25 MUSD+119.49%
86.22 MUSD+17.23%
73.55 MUSD+1,109.32%
6.08 MUSD-181.08%
-7.50 MUSD-80.74%
-38.94 MUSD-181.97%
47.51 MUSD-5,676.06%
-852,000.00USD-173.13%
1.17 MUSD-186.30%
-1.35 MUSD-132.30%
4.18 MUSD+38.88%
3.01 MUSD-367.23%
-1.13 MUSD-132.85%
3.43 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Penumbra Revenue

Penumbra Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
847.13 M USD
6.08 M USD
-2.00 M USD
Jan 1, 2023
1.06 B USD
73.55 M USD
90.95 M USD
Jan 1, 2024
1.19 B USD
86.22 M USD
14.01 M USD
Jan 1, 2025
1.40 B USD
189.25 M USD
177.69 M USD
Jan 1, 2026 (e)
1.59 B USD
243.10 M USD
186.42 M USD
Jan 1, 2027 (e)
1.80 B USD
313.84 M USD
234.99 M USD
Jan 1, 2028 (e)
2.02 B USD
365.38 M USD
274.04 M USD
Jan 1, 2029 (e)
2.15 B USD
398.39 M USD
313.06 M USD

Penumbra Margins

Penumbra stock margins

The Penumbra margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Penumbra. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Penumbra.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
63.18 %
0.72 %
-0.24 %
Jan 1, 2023
64.49 %
6.95 %
8.59 %
Jan 1, 2024
63.20 %
7.22 %
1.17 %
Jan 1, 2025
67.14 %
13.48 %
12.66 %
Jan 1, 2026 (e)
67.14 %
15.29 %
11.72 %
Jan 1, 2027 (e)
67.14 %
17.44 %
13.05 %
Jan 1, 2028 (e)
67.14 %
18.05 %
13.54 %
Jan 1, 2029 (e)
67.14 %
18.50 %
14.53 %

Penumbra Stock analysis

What does Penumbra do? Penumbra Inc is an American company specializing in medical technology. It was founded in 2004 and is headquartered in Alameda, California. The company has branches and subsidiaries worldwide. It offers various products for the treatment of strokes, aneurysms, vascular injuries, and other medical conditions. The history of Penumbra Inc began with the founder and CEO Adam Elsesser's vision to develop innovative technologies to help patients with challenging medical conditions. The company started with just one product, the Penumbra 3D Coiling Technology, which is used for the treatment of brain aneurysms. Penumbra Inc's business model is based on the development and marketing of innovative medical devices and technologies to assist surgeons and specialists in treating their patients better. The company conducts intensive research and development to create new products that meet market demand. Penumbra Inc is divided into different divisions to offer a comprehensive range of medical tools and devices to its customers. The main divisions of the company are Neuro, Vascular, and Oncology. Under the Neuro division, Penumbra Inc offers a wide range of devices and technologies for the treatment of strokes and trauma. This includes the Penumbra Coil 400, used for treating intracranial aneurysms, and the Penumbra Jet 7 Reperfusion Catheter, an innovative technology for restoring blood flow in stroke patients' brains. The Vascular division of Penumbra Inc provides devices for the treatment of vascular diseases, such as endovascular repairs of aortic aneurysms. This division utilizes the innovative Penumbra SMART Coil technology, which provides improved handling and safety. The Oncology division of Penumbra Inc focuses on developing technologies to enhance healthcare for cancer patients. This includes innovative drug delivery devices, such as the Penumbra System used in brachytherapy. Penumbra Inc is a leading provider of medical devices and technologies used in the treatment of complex medical conditions. Over the past decade, the company has established its reputation in the industry. Continuous investment in research and development and a focus on patient and medical professionals' needs have solidified Penumbra Inc's success in the international market. Penumbra is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Penumbra's EBIT

Penumbra's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Penumbra's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Penumbra's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Penumbra’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Penumbra stock

EBIT of Penumbra is 189.25 M USD in 2025.

EBIT of Penumbra changed from 86.22 M USD to 189.25 M USD, representing a 119.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Penumbra since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Penumbra historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Penumbra

All Key Metrics — Penumbra